Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Yamanouchi synthesizes macrocyclic antitumor agents

Feb. 13, 2002

Estramustine analogues have a promising preclinical profile of antitumor activity

Feb. 13, 2002

Tumor-targeting polymer conjugate will be codeveloped by Tanabe and Menarini

Feb. 13, 2002

Letrozole superior to anastrozole in reducing estrogen production in breast cancer patients

Feb. 12, 2002

Toxicology studies completed for Reolysin

Feb. 12, 2002

Pharmacia discontinues SU-5416 clinical program

Feb. 12, 2002

Silico Insights and Genzyme Molecular Oncology enter oncogenic collaboration

Feb. 12, 2002

Combination of 2-methoxyestradiol with oxidative stress associated with enhanced antitumor activity

Feb. 12, 2002

Orally administered S-23906-1 evaluated for activity in metastatic colon cancer models

Feb. 12, 2002

Approval for Metvix PDT in New Zealand

Feb. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...